Australian private equity firm Crescent Capital Partners has acquired clinical research organization (CRO) Nucleus Network from The Baker Institute, an independent research institute focussed on heart disease and diabetes, according to a press release.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
